ORIGINAL INVESTIGATIONS Pathogenesis and Treatment of Kidney Disease Early Urinary Markers of Diabetic Kidney Disease: A Nested Case-Control Study From the Diabetes Control and Complications Trial (DCCT)

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Impaired tubular uptake explains albuminuria in early diabetic nephropathy.

  2009cited by this paper
• Effects of Advanced Glycation End Product Modification on Proximal Tubule Epithelial Cell Processing of Albumin

  2007cited by this paper
• Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics.

  2007cited by this paper
• Urinary N-Acetyl B Glucosaminidase as an Earlier Marker of Diabetic Nephropathy and Influence of Low-Dose Perindopril/Indapamide Combination

  2006cited by this paper
• Renal albumin absorption in physiology and pathology.

  2006cited by this paper
• Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes.

  2005cited by this paper
• Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stress.

  2005cited by this paper
• Glomerular handling of native albumin in the presence of circulating modified albumins by the normal rat kidney.

  2005cited by this paper
• Significance of Proximal Tubular Metabolism of Advanced Glycation End Products in Kidney Diseases

  2005cited by this paper
• Kidney function in early diabetes: the tubular hypothesis of glomerular filtration.

  2004cited by this paper
• Ramipril prevents microtubular changes in proximal tubules from streptozotocin diabetic rats

  2003cited by this paper
• Pathophysiology of proteinuria.

  2003cited by this paper
• Markers of renal tubular dysfunction measured annually do not predict risk of microalbuminuria in the first few years after diagnosis of Type I diabetes

  2001cited by this paper
• Albuminuria in patients with type 1 diabetes is directly linked to changes in the lysosome-mediated degradation of albumin during renal passage.

  2000cited by this paper
• Urine N-acetyl-beta-D-glucosaminidase--a marker of tubular damage?

  1999cited by this paper
• Metallothionein protects against the nephrotoxicity produced by chronic CdMT exposure.

  1999cited by this paper
• Relationship Between Serum 1,5-Anhydroglucitol and Urinary Excretion of N-Acetylalucosaminidase and Albumin Determined at Onset of NIDDM With 3-Year Follow-up

  1998cited by this paper
• Free pentosidine and neopterin as markers of progression rate in diabetic nephropathy. Collaborative Study Group.

  1998cited by this paper
• Predictive Value of Tubular Markers for the Development of Microalbuminuria in Adolescents with Diabetes

  1998cited by this paper
• Specific fluorescence assay for advanced glycation end products in blood and urine of diabetic patients.

  1998cited by this paper
• Markers of diabetic nephropathy.

  1998cited by this paper
• Urinary N-acetyl-beta-D-glucosaminidase activity in children with insulin-dependent diabetes mellitus.

  1996cited by this paper
• Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells

  1996cited by this paper
• Magnitude of end-stage renal disease in IDDM: a 35 year follow-up study.

  1996cited by this paper
• Urinary beta 2-microglobulin levels and urinary N-acetyl-beta-D-glucosaminidase enzyme activities in early diagnosis of non-insulin-dependent diabetes mellitus nephropathy.

  1994cited by this paper
• Erratum: Baseline analysis of renal function in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group (Kidney International 43 (1993) 668-674)

  1993cited by this paper
• Glomerular filtration and tubular reabsorption of albumin in preproteinuric and proteinuric diabetic rats.

  1993cited by this paper
• Baseline analysis of renal function in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group [corrected].

  1993cited by this paper
• Size- and charge selectivity of glomerular filtration in Type 1 (insulin-dependent) diabetic patients with and without albuminuria

  1993cited by this paper
• Short- and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes.

  1993cited by this paper
• The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy.

  1993cited by this paper
• Markers for the diagnosis and monitoring of renal tubular lesions.

  1992cited by this paper
• Glomerular size-selectivity and microalbuminuria in early diabetic glomerular disease.

  1992cited by this paper
• Chromatographic Quantitation of Plasma and Erythrocyte Pentosidine in Diabetic and Uremic Subjects

  1992cited by this paper
• Association between urinary N-acetyl-beta-glucosaminidase and its isoenzyme patterns and microangiopathy in type 1 diabetes mellitus.

  1991cited by this paper
• Urinary excretion of beta-thromboglobulin and N-acetyl-beta-D-glucosaminidase in type 1 diabetes: potential indicators of early nephropathy?

  1990cited by this paper
• Urinary N-acetyl-beta-D-glucosaminidase excretion in insulin-dependent diabetes mellitus: relation to microalbuminuria, retinopathy and glycaemic control.

  1988cited by this paper
• Effect of glycation of albumin on its renal clearance in normal and diabetic rats.

  1988cited by this paper
• Suggested mechanism for the selective excretion of glucosylated albumin. The effects of diabetes mellitus and aging on this process and the origins of diabetic microalbuminuria

  1987cited by this paper
• Biased selection of controls for case-control analyses of cohort studies.

  1984cited by this paper
• Simple, rapid spectrophotometry of urinary N-acetyl-beta-D-glucosaminidase, with use of a new chromogenic substrate.

  1983cited by this paper

• Revisiting the Role of NAG across the Continuum of Kidney Disease

  2023cites this paper
• Evaluation of N-acetyl-β-D-glucosaminidase as a prognostic marker for diabetic nephropathy in type 2 diabetics: systematic review and meta-analysis

  2023cites this paper
• Posterior urethral valve in children: Using novel biomarkers as an early predictive tool for the onset and progression of chronic kidney disease

  2022cites this paper
• Up-Date on Diabetic Nephropathy

  2022cites this paper
• Pathophysiology of Diabetic Kidney Disease

  2022cites this paper
• Advanced Glycation End Products (AGEs) and Chronic Kidney Disease: Does the Modern Diet AGE the Kidney?

  2022cites this paper
• The nephropathy of sickle cell trait and sickle cell disease

  2022cites this paper
• Association between Urinary Advanced Glycation End Products and Subclinical Inflammation in Children and Adolescents: Results from the Italian I.Family Cohort

  2022cites this paper
• Association between urinary N-acetyl-β-glucosaminidase activity–urinary creatinine concentration ratio and risk of disability and all-cause mortality

  2022cites this paper
• The Assessment of the Usefulness of Selected Markers in the Diagnosis of Chronic Kidney Disease in Children

  2021cites this paper
• Multi sensor application-based for measuring the quality of human urine on first-void urine

  2021cites this paper
• DNA aptamer raised against receptor for advanced glycation end products suppresses renal tubular damage and improves insulin resistance in diabetic mice

  2021cites this paper
• The effect of co-enzyme Q10 and N-acetylcysteine on biochemical parameters and oxidative stress in rats subjected to alloxan induced diabetic nephropathy

  2021cites this paper
• Cyclophilin A (CyPA) as a Novel Biomarker for Early Detection of Diabetic Nephropathy in an Animal Model

  2020cites this paper
• Possible Biomarkers for Diabetic Kidney Disease

  2020cites this paper
• Features of biochemical parameters in healthy and patients with type 1 diabetes mellitus with different levels of albumin in the urine

  2020cites this paper
• Urinary biomarkers in lupus nephritis

  2020cites this paper
• Panel of novel urine biomarkers for incident microalbuminuria in people with type 2 diabetes mellitus

  2020cites this paper
• SERUM PENTOSIDINE ASSAY AMONG DIABETIC NEPHROPATHY PATIENTS IN SOUTH-SOUTH NIGERIA

  2020cites this paper
• Animal Models and Renal Biomarkers of Diabetic Nephropathy.

  2020cites this paper
• Hyperinsulinemia contributes to impaired-glucose-tolerance-induced renal injury via mir-7977/SIRT3 signaling

  2020cites this paper
• Insights into predicting diabetic nephropathy using urinary biomarkers.

  2020cites this paper
• DMSO_A_260293 3807..3819

  2020cites this paper
• Evaluation of urinary biomarkers for prediction of diabetic kidney disease: a propensity score matching analysis

  2019cites this paper
• The renal resistive index as a new complementary tool to predict microvascular diabetic complications in children and adolescents: a groundbreaking finding.

  2019cites this paper
• Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients

  2019cites this paper
• PREVALENCE OF DIABETIC NEPHROPATHY IN CHILDREN AND ADOLESCENTS IN THE KYRGYZ REPUBLIC

  2019cites this paper
• Serum and Urine Neutrophil Gelatinase- Associated Lipocalin: As an Indicator for Early Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients

  2019cites this paper
• Elevated urinary N-acetyl-β-D-glucosaminidase is associated with high glycoalbumin-to-hemoglobin A1c ratio in type 1 diabetes patients with early diabetic kidney disease

  2018cites this paper
• Neutrophil Gelatinase-associated Lipocalin: As a Predictor of Early Diabetic Nephropathy in Type 2 Diabetes Mellitus

  2018cites this paper
• The Promise of Systems Biology for Diabetic Kidney Disease.

  2018cites this paper
• Early markers of heart and kidney damage in Fabry disease

  2018cites this paper
• Elevated N-acetyl-β-d-glucosaminidase, a urinary tubular damage marker, is a significant predictor of carotid artery atherosclerosis in type 1 diabetes, independent of albuminuria: A cross-sectional study.

  2018cites this paper
• Biomarkers of Common Childhood Renal Diseases Biomarkers of Common Childhood Renal Diseases

  2018cites this paper
• New Tubulocentric Insights for Diabetic Nephropathy: From Pathophysiology to Treatment

  2018cites this paper
• Non-invasive detection of the early phase of kidney injury by photoacoustic/computed tomography imaging

  2018cites this paper
• Antioxidant and antihyperglycaemic effects of naringenin arrest the progression of diabetic nephropathy in diabetic rats

  2017cites this paper
• Prediction and monitoring of chronic kidney disease

  2017cites this paper
• Soluble plasma proteins ST2 and CD163 as early biomarkers of nephropathy in Swedish patients with diabetes, 15–34 years of age: a prospective cohort study

  2017cites this paper
• The renal tubular damage marker urinary N-acetyl-β-d-glucosaminidase may be more closely associated with early detection of atherosclerosis than the glomerular damage marker albuminuria in patients with type 2 diabetes

  2017cites this paper
• Deregulated profiles of urinary microRNAs may explain podocyte injury and proximal tubule dysfunction in normoalbuminuric patients with type 2 diabetes mellitus

  2017cites this paper
• Performance of urinary kidney injury molecule-1, neutrophil gelatinase-associated lipocalin, and N-acetyl-β-D-glucosaminidase to predict chronic kidney disease progression and adverse outcomes

  2017cites this paper
• A more tubulocentric view of diabetic kidney disease

  2017cites this paper
• N -Acetyl- b - D -Glucosaminidase Does Not Enhance Prediction of Cardiovascular or All-Cause Mortality by Albuminuria in a Low-Risk Population

  2016cites this paper
• Effect of Bergenin on the Kidney of C57BL/6J Mice with High Fat-Diet Induced Oxidative Stress

  2016cites this paper
• Tofogliflozin, a selective inhibitor of sodium-glucose cotransporter 2, suppresses renal damage in KKAy/Ta mice, obese and type 2 diabetic animals

  2016cites this paper
• Early detection of diabetic kidney disease: Present limitations and future perspectives.

  2016cites this paper
• N-Acetyl-β-D-Glucosaminidase Does Not Enhance Prediction of Cardiovascular or All-Cause Mortality by Albuminuria in a Low-Risk Population.

  2016cites this paper
• Effect of Bergenin on the Kidney of C57BL/6J Mice with High Fat-Diet Induced Oxidative Stress

  2016cites this paper
• Urinary Markers for Early Detection of Diabetic Nephropathy in Type 1 Diabetes Mellitus

  2015cites this paper
• Elevated Urinary Connective Tissue Growth Factor in Diabetic Nephropathy Is Caused by Local Production and Tubular Dysfunction

  2015cites this paper
• Biomarkers of Renal Disease and Progression in Patients with Diabetes

  2015cites this paper
• Will the future lie in multitude? A critical appraisal of biomarker panel studies on prediction of diabetic kidney disease progression.

  2015cites this paper
• Urinary biomarker N-acetyl-β-D-glucosaminidase can predict severity of renal damage in diabetic nephropathy

  2015cites this paper
• Kidney Injury Molecule-1 and the Loss of Kidney Function in Diabetic Nephropathy: A Likely Causal Link in Patients With Type 1 Diabetes

  2015cites this paper
• Prediction of development and maintenance of high albuminuria during chronic renin-angiotensin suppression by plasma proteomics.

  2015cites this paper
• Diabetic Nephropathy: New Risk Factors and Improvements in Diagnosis.

  2015cites this paper
• Glycated peptides are associated with proximal tubule dysfunction in type 2 diabetes mellitus.

  2015cites this paper
• Urinary N-acetyl-β-D-glucosaminidase (NAG) activity in the early detection of diabetic nephropathy

  2015cites this paper
• RBP urinária e sérica: associação com doença renal crônica e fatores de risco cardiovascular

  2015cites this paper
• Biomarkers in chronic kidney disease, from kidney function to kidney damage.

  2015cites this paper
• Determination of early urinary renal injury markers in obese children

  2014cites this paper
• Proximal Tubule Dysfunction Is Associated with Podocyte Damage Biomarkers Nephrin and Vascular Endothelial Growth Factor in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study

  2014cites this paper
• Clinical Study Association between Urinary N-Acetyl-Beta-D-Glucosaminidase andMicroalbuminuria in Diabetic Black Africans

  2014cites this paper
• Biomarkers in diabetic nephropathy: Present and future.

  2014cites this paper
• Screening for microalbuminuria as an early marker of diabetic nephropathy in type 2 diabetic patients

  2014cites this paper
• Glomerular and tubular damage markers in individuals with progressive albuminuria.

  2013cites this paper
• Establishing a high risk CKD cohort: cross-sectional analysis and early outcomes

  2013cites this paper
• Kidney disease in disadvantaged populations: still a Herculean challenge

  2013cites this paper
• Epithelial Cells as Active Player In Fibrosis: Findings from an In Vitro Model

  2013cites this paper
• Urinary MCP-1 and RBP: independent predictors of renal outcome in macroalbuminuric diabetic nephropathy.

  2012influential citation
• SIGNAL TRANSDUCTION IN DIABETIC NEPHROPATHY By MICHAEL SCOTT SIMONSON Submitted in partial fulfillment of the requirements For the degree of Doctor of Philosophy

  2012cites this paper
• Cardiovascular risk and its determinants in high risk patients

  2012cites this paper
• Urinary markers of glomerular and tubular damage in chronic kidney disease

  2012cites this paper
• Маркеры аутоиммунного поражения печени у пациентов с сахарным диабетом 1 типа

  2012cites this paper
• Effects of interventions in the RAAS and sodium status on classical and non-classical outcome parameters in chronic kidney disease

  2012cites this paper
• Proximal tubule dysfunction in renal diseases - dia gnostic significance of proteomics and biomarkers Disfunc Ńia tubular ă proximală în boala renal ă - importan Ńa diagnostic ă a proteomiciii biomarkerilor

  2012cites this paper
• Association between Urinary N-Acetyl-Beta-D-Glucosaminidase and Microalbuminuria in Diabetic Black Africans

  2012cites this paper
• The renal transcriptome of db/db mice identifies putative urinary biomarker proteins in patients with type 2 diabetes: a pilot study.

  2012cites this paper
• Correlation between Asymptomatic Leukocyturia and Urinary N-Acetyl-β-d-glucosaminidase in Women

  2012cites this paper
• Urinary N‐acetyl‐β‐d‐Glucosaminidase Levels are Positively Correlated With 2‐Hr Plasma Glucose Levels During Oral Glucose Tolerance Testing in Prediabetes

  2012cites this paper
• COMPARISON OF URINARY N-ACETYL-BETA-D-GLUCOSAMINIDASE IN NON-DIABETIC SUBJECTS AND TYPE2 DIABETIC PATIENTS

  2011cites this paper
• Thoracic malignancies, cisplatin and renal function

  2011cites this paper
• Assessment of urinary γ-glutamyltransferase and alkaline phosphatase for diagnosis of diabetic nephropathy.

  2011cites this paper
• Skin autofluorescence as a measure of advanced glycation endproduct deposition: a novel risk marker in chronic kidney disease

  2010cites this paper
• Urinary tubular biomarkers of kidney damage: potential value in clinical practice.

  2010cites this paper
• The use of targeted biomarkers for chronic kidney disease.

  2010cites this paper
• Proximal tubule dysfunction in renal diseases-diagnostic significance of proteomics and biomarkers

  year unknowncites this paper